DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-52.1%
Review Clorox Co. (CLX) valuation assumptions across intrinsic value, DCF, reverse DCF implied growth, EV/EBITDA, P/FCF, and financial trends.
US · US · USD
What price implies
At 87.11 USD, the model implies roughly -2.01% annual FCF growth for 10 years, with required long-term operating margin near Assumption unavailable and terminal growth around 3%. This module is a research reference.
10-year Reverse DCF scenario
Five-year median × 0.95
From current model assumptions
Estimated from current sector rules
Move assumptions to see how the current price implied conditions change.
Valuation overview
Clorox Co. (CLX) valuation on TickerVal is designed to help readers understand the operating expectations embedded in the current market price. At 87.11 USD, the page brings intrinsic value analysis, DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, and valuation assumptions into one research view within the Consumer Defensive sector and the Household & Personal Products industry. Instead of treating one model as a final answer, TickerVal compares cash-flow, earnings-power, balance-sheet, and relative-multiple lenses so the differences between models are visible. The reverse DCF view currently shows implied growth of -2.0%, while the model median reference sits at a limited composite reference versus the current price. The DCF and reverse DCF sections focus on free cash flow, discount rate, terminal growth, and the long-term growth path implied by the current price. EV/EBITDA and P/FCF provide additional context for capital structure and cash-flow multiples. The financial trends section connects those valuation assumptions back to reported revenue of 7B USD, free cash flow of 780M USD, margins, and balance-sheet facts from public filings. Readers can use the layout to compare assumptions across models before reviewing the underlying source data. This page is intended for transparent research reference, model review, and assumption checking.
Each row shows a model output range, with a vertical line for the current price.
Different models rely on different financial facts. The status blocks show which lenses fit this page data.
| Model | Fit | Context |
|---|---|---|
| DCF | Suitable | Useful when recurring free cash flow history exists; sensitive to growth and discount assumptions. |
| Owner Earnings | Limited | Latest owner-earnings proxy is an outlier, so this is a limited scenario reference. |
| Reverse DCF | Suitable | Shows the FCF growth implied by current price under stated assumptions. |
| Earnings Power Value | Not meaningful | Useful for mature operating profit, with limited emphasis on growth. |
| Graham Number | Limited | Works best when EPS and book value are both positive. |
| Dividend Discount Model | Not meaningful | Needs explicit dividend history, which is not included in the current version. |
| Net-Net Liquidation Value | Not meaningful | Requires current asset and liability detail beyond the current data set. |
| PEG | Limited | A quick growth multiple lens when EPS history is positive. |
| EV/EBITDA | Not meaningful | Useful for capital structure context when operating profit is available. |
| P/FCF | Limited | A compact free-cash-flow multiple view for positive FCF years. |
| P/B | Limited | More useful for asset-heavy balance sheets than asset-light companies. |
| P/S | Limited | A revenue multiple lens when profit or FCF is not stable. |
| Peer Comparison | Not meaningful | Standardized peer comparisons are not included in the current version. |
Hover each model row to inspect formulas and inputs.
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-52.1%
Uses net income, D&A, and capex as an owner-earnings proxy.
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -2.0% annualized FCF growth.
Estimates earnings power value without assuming growth.
Updated: 2026/05/03
Annual financial metrics with switchable views. · Unit: USD
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/06/30 | Asset impairment | Impairment | -352M USD | Medium |
| 2025/06/30 | Restructuring charges | Restructuring | -23M USD | Medium |
| 2023/06/30 | Asset impairment | Impairment | -260M USD | Medium |
| 2023/06/30 | Restructuring charges | Restructuring | -56M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | Annual | 7B USD | 810M USD | 1B USD | 780M USD | 6.52 | 9.53 |
| 2024/06/30 | Annual | 7B USD | 280M USD | - | 499M USD | 2.25 | - |
| 2023/06/30 | Annual | 7B USD | 149M USD | 465M USD | 946M USD | 1.2 | 3.74 |
| 2022/06/30 | Annual | 7B USD | 462M USD | - | 551M USD | 3.73 | - |
| 2021/06/30 | Annual | 7B USD | 710M USD | -59M USD | 945M USD | 5.58 | -0.47 |
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
Quick notes on price-implied expectations, model differences, and source data.
Clorox Co.'s intrinsic value on TickerVal is reviewed through DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, valuation assumptions, and financial trends from public filings.
TickerVal values CLX by comparing intrinsic value models, DCF and reverse DCF assumptions, cash-flow multiples, earnings-power references, and reported financial trends.
The reverse DCF view estimates the free-cash-flow growth path implied by the current stock price under stated discount-rate and terminal-growth assumptions.
TickerVal uses DCF, reverse DCF, Owner Earnings, EPV, Graham Number, EV/EBITDA, P/FCF, P/B, P/S, and other model references where the underlying data is available.
No. TickerVal does not provide investment advice, ratings, price targets, or buy/sell recommendations.
Early supporter list
Join the research reference list for product updates, model notes, and transparent assumption workflows.
TickerVal is a research workspace, not a financial advisor. Pages on this site do not provide investment, legal, or tax advice and do not contain buy, sell, hold, ratings, price targets, or personalized recommendations. Financial data is derived from public company filings available through SEC EDGAR. TickerVal independently normalizes and computes valuation assumptions; figures may differ from company reports or other providers. TickerVal is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.
Total revenue recognized in each fiscal year.